- Home
- » Tags
- » Radiopharmaceutical
Top View
- Adreview (Iobenguane I 123 Injection) Label
- Unparalleled Contribution of Technetium-99M to Medicine Over 5 Decades
- Technetium-99M Radiopharmaceutical Preparation Problems: 12 Years of Experience
- CP.PHAR.459 Iobenguane I-131 (Azedra)
- A Perspective on the Radiopharmaceutical Requirements for Imaging and Therapy of Glioblastoma
- A Picture of Modern Tc-99M Radiopharmaceuticals: Production, Chemistry, and Applications in Molecular Imaging
- Technetium-99M Pharmaceuticals
- Radiopharmaceutical Agent/Protocol-Specific Procedure
- Final Core Smpc Sestamibi
- Trends in Radiopharmaceuticals
- IODINE ISOTOPES & Nuclear Medicine I-123
- Excretion of Iodine- 123-Hippuran, Technetium-99M-Red Blood Cells, and Technetium-9 9M-Macroaggregated Albumin Into Breast Milk
- Radionuclide Metabolic Therapy Clinical Aspects, Dosimetry and Imaging
- SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0*
- Glossary: Definitions and Terminology
- Chapter 14 Nuclear Medicine Outline Introduction Radiopharmaceuticals Radiopharmaceuticals Mechanisms of Localization
- Radiopharmaceuticals
- Billing and Coding Guidelines for Radiopharmaceutical Agents (RAD-026)
- Manual on THERAPEUTIC USES of IODINE-131
- Basics of Radiopharmacy
- Sodium Iodide I 131 Capsule USP Diagnostic – Oral
- Breakage of Technetium-99M-Sestamibi Vial
- Chapter 2 Technetium in Medicine 2
- 123-I MIBG Imaging: Patient Preparation and Technologist's Role
- Adverse Events of Diagnostic Radiopharmaceuticals Schreuder, Nanno; Koopman, Daniëlle; Jager, Pieter L.; Kosterink, Jos G
- Acr–Acnm–Astro–Snmmi–Spr Practice Parameter for Treatment of Benign and Malignant Thyroid Disease with I- 131 Sodium Iodide
- The Radiopharmacy a Technologist’S Guide
- EANM Procedure Guidelines for Brain Neurotransmission SPECT Using 123I-Labelled Dopamine Transporter Ligands, Version 2
- 'Cyclotron Production of Iodine-123'
- Fast Labeling of Technetium-99M-Sestamibi with Microwave Oven Heating
- Altered Biodistribution of Radiopharmaceuticals: Role of Radiochemical/Pharmaceutical Purity, Physiological, and Pharmacologic Factors
- I-131 Meta-Iodobenzylguanidine (Iobenguane Sulfate) (MIBG)
- 〈825〉 Radiopharmaceuticals—Preparation, Compounding, Dispensing, 3 and Repackaging. Radiopharmaceuticals
- Technetium-99M Radiopharmaceuticals: Status and Trends
- Comparative Evaluation of Iodine-123 and Technetium-99
- Radiopharmacy Prof
- 99Mtc Sestamibi
- Radiopharmacy: an Update
- Regulatory Guide 8.39, Release of Patients Administered Radioactive
- Technetium-99M Radiopharmaceuticals: Manufacture of Kits of Manufacture Radiopharmaceuticals: Technetium-99M Technetium-99M Radiopharmaceuticals: Manufacture of Kits
- Interpreting 123I-Ioflupane Dopamine Transporter Scans Using Hybrid Scores. K
- Adverse Reactions to Radiopharmaceuticals (ARRP): Particularly to Technetium Radiopharmaceuticals
- Datscan, Ioflupane (I-123)
- Adverse Events of Diagnostic Radiopharmaceuticals: a Systematic Review Nanno Schreuder, Pharmd,*,† Danielle€ Koopman, Msc,ǂ,{ Pieter L
- Therapeutic Applications of Radiopharmaceuticals
- Sodium Iodide I 131 Capsules USP Diagnostic - Oral
- Oncology Therapeutic Radiopharmaceuticals: Nonclinical Studies and Labeling Recommendations Guidance for Industry
- Radiopharmaceutical Therapy in Cancer: Clinical Advances and Challenges
- Technetium Radiopharmaceutical Chemistry
- Brain Datscan® (I-123 Ioflupane) SPECT
- Clinical and Technical Considerations for Imaging Colorectal Cancers with Technetium-99M-Labeled Anticea Fab Fragment
- Annex I Summary of Product Characteristics
- Radiopharmaceuticals for Therapy
- Current Directions in Radiopharmaceutical Research
- Sodium Iodide 1-123 Is Administered at Calibration Or at Expiry
- Radiopharmaceuticals for Sentinel Lymph Node Detection : Status and Trends
- Are Their Peculiarities Adequately Reflected in European Legislation?
- Iobenguane I 131) Injection, for Intravenous Use Ranged from 12 Months to 7 Years
- Technetium - 99M Radiological Safety Guidance Revision Date: 09/20/18
- AMM Template
- Annual Report 2015 Annexes